Neurelis, Inc., is a leading neuroscience company focused on the development and commercialization of therapeutics for the treatment of epilepsy and other neurologic disorders. Our unique drug portfolios strive to address unmet needs in patient care.
Location: United States, California, San Diego
Employees: 51-200
Total raised: $264M
Founded date: 2007
Investors 2
| Date | Name | Website |
| - | OrbiMed | orbimed.co... |
| - | HBM Partne... | hbmpartner... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 11.08.2021 | - | $150M | OrbiMed | orbimed.co... |
| 11.03.2021 | Series D | $114M | - | finsmes.co... |
Mentions in press and media 17
| Date | Title | Description | Source |
| 18.10.2023 | Aculys Pharma delivers positive Phase 3 clinical study inter... | These results are from Japan's first domestic Phase 3 clinical trial of an intranasally administered... | en.prnasia... |
| 23.01.2023 | Startups measuring the brain that you need to know | Companies are using biomarkers to diagnose and treat mental illness and other neurological disorders... | vator.tv/n... |
| 26.01.2022 | Aculys Pharma signed an exclusive licensing agreement with N... | Aculys Pharma, Inc. (“Aculys Pharma” Headquarters: Fujisawa City, Kanagawa Prefecture, Representativ... | catalyspac... |
| 11.08.2021 | Neurelis Secures Senior Term Loan Facility Of Up To $150 Mil... | - | orbimed.co... |
| 11.08.2021 | Neurelis Receives $150M Senior Term Loan Facility From OrbiM... | - | connect.or... |
| 11.08.2021 | Neurelis Secures Senior Term Loan Facility Of Up To $150 Mil... | SAN DIEGO, Aug. 11, 2021 /PRNewswire/ -- Neurelis, Inc., announced today that it has completed a s... | prnewswire... |
| 19.04.2021 | Neurelis Announces Five Poster Presentations for the Annual ... | SAN DIEGO, April 19, 2021 /PRNewswire/ -- Neurelis, Inc., announced today that it is presenting fi... | prnewswire... |
| 12.04.2021 | Neurelis Announces Two Poster Presentations for the Annual M... | SAN DIEGO, April 12, 2021 /PRNewswire/ -- Neurelis, Inc., announced today that it is presenting tw... | prnewswire... |
| 11.03.2021 | Neurelis has raised a $114M Series D to commercialize its le... | - | connect.or... |
| 11.03.2021 | Neurelis Raises $114M in Series D Financing | Neurelis, Inc., a San Diego, CA-based neuroscience company, closed a $114m Series D financing round.... | finsmes.co... |
Show more